Jim Tananbaum contributions to Mindstrong Health

Mindstrong Health is a startup company that aims at using smartphones to aid and diagnose in the treatment of neuropsychiatric diseases. According to reports, the startup secured more than fourteen million dollars in funding from investors. Foresite Capital, Optum Ventures, ARCH Venture Partners, and One Mind Brain Health Impact Fund led the series-A funding.

 

According to Jim Tananbaum, the CEO of Foresite Capital, the founders of Mindstrong Health bring an excellent understanding of the fundamental challenges around the way medical communities care for individuals with cognitive health disorders. Jim adds that bringing together Tom, Paul, and Rick’s collective experience, skills leadership and professional ambition, those interested in improving patient’s health will have an innovative platform that vastly improves and modernizes the methods in which health care is given.

 

About Jim Tananbaum

 

Jim is a great pioneer with more than 25 years’ experience in healthcare and investment. He is the founder of Foresite Capital. His inspiration to begin the organization was the yearning to consolidate components of all parts of his career to make a remarkable venture platform. He concentrates on operational, strategic and investment opportunities to construct an establishment a franchise healthcare business. He has been the chief strategist at Foresite Capitals investment organization structure and business system. Todd assumed a critical part in a few portfolio organizations of Foresite Capital.

 

Before beginning Foresite Capital, Jim helped to establish two co-founded healthcare investment practices and two biopharmaceutical firms. Jim went to Harvard University medical and business colleges. While completing his course at Harvard, he began GelTex Pharmaceuticals.

 

The organization introduced two medications to the market for under $80M. The group was purchased in 1998 for $1.6 billion. At that time, the first medicine Renagel had a yearly income rate of more than $200M. Right now, the medication is estimated to make an annual salary of near a billion. Another organization that Jim helped to establish and served, as CEO is Theravance, Inc. these two agencies have a joined market capitalization of $3.2B. Check out Medium to know more.

 

In conclusion, Jim had help other positions in the healthcare industry and succeeded in each one of them.

 

 

Visit officialjimtananbaum.com

 

 

See more: https://www.linkedin.com/in/jim-tananbaum-a7562a7/

Leave a Comment

Your email address will not be published. Required fields are marked *